Skip to main content
MedicHelpLine
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsORALStandard

BACLOFEN

BACLOFEN

Standard Dose
5MG/5ML
Max Dose
Refer to approved labeling
Primary Use
Review priority: UNKNOWN Marketing status: Prescription
Summary

Approval overview BACLOFEN is listed in Drugs@FDA under application 214445 (ANDA).

Review priority: UNKNOWN Marketing status: Prescription Active ingredient BACLOFEN Form and strength SOLUTION;ORAL - 5MG/5ML Sponsor RUBICON RESEARCH Submission history Latest submission status date: 2025-06-03 00:00:00.

Structured Monograph

Clinical summary

Approval overview BACLOFEN is listed in Drugs@FDA under application 214445 (ANDA). Review priority: UNKNOWN Marketing status: Prescription Active ingredient BACLOFEN Form and strength SOLUTION;ORAL - 5MG/5ML Sponsor RUBICON RESEARCH Submission history Latest submission status date: 2025-06-03 00:00:00. Submission type: SUPPL.

Monitoring

  • Marketing status: Prescription
  • Review priority: UNKNOWN

Interaction Notes

  • No interaction notes stored yet.
BACLOFEN (BACLOFEN) | Drug Monograph | MedicHelpline